Fortrea (FTRE) Competitors $10.13 +0.82 (+8.81%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$10.19 +0.06 (+0.59%) As of 10/8/2025 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTRE vs. WGS, HTFL, PRVA, VCYT, SGRY, CON, GRAL, LFST, CELC, and ADUSShould you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include GeneDx (WGS), Heartflow (HTFL), Privia Health Group (PRVA), Veracyte (VCYT), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), GRAIL (GRAL), LifeStance Health Group (LFST), Celcuity (CELC), and Addus HomeCare (ADUS). These companies are all part of the "healthcare" industry. Fortrea vs. Its Competitors GeneDx Heartflow Privia Health Group Veracyte Surgery Partners Concentra Group Holdings Parent GRAIL LifeStance Health Group Celcuity Addus HomeCare GeneDx (NASDAQ:WGS) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings. Do analysts prefer WGS or FTRE? GeneDx presently has a consensus target price of $104.13, suggesting a potential downside of 15.13%. Fortrea has a consensus target price of $12.17, suggesting a potential upside of 20.11%. Given Fortrea's higher possible upside, analysts plainly believe Fortrea is more favorable than GeneDx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GeneDx 1 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50Fortrea 2 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.08 Does the media refer more to WGS or FTRE? In the previous week, Fortrea had 5 more articles in the media than GeneDx. MarketBeat recorded 15 mentions for Fortrea and 10 mentions for GeneDx. Fortrea's average media sentiment score of 0.61 beat GeneDx's score of 0.27 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GeneDx 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Fortrea 4 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, WGS or FTRE? GeneDx has a beta of 1.98, meaning that its stock price is 98% more volatile than the S&P 500. Comparatively, Fortrea has a beta of 1.81, meaning that its stock price is 81% more volatile than the S&P 500. Which has better earnings & valuation, WGS or FTRE? GeneDx has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than GeneDx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGeneDx$362.32M9.73-$52.29M$0.052,453.80Fortrea$2.70B0.34-$328.50M-$11.38-0.89 Is WGS or FTRE more profitable? GeneDx has a net margin of 0.39% compared to Fortrea's net margin of -37.57%. GeneDx's return on equity of 16.51% beat Fortrea's return on equity.Company Net Margins Return on Equity Return on Assets GeneDx0.39% 16.51% 9.35% Fortrea -37.57%5.25%1.72% Do institutionals and insiders hold more shares of WGS or FTRE? 61.7% of GeneDx shares are held by institutional investors. 29.6% of GeneDx shares are held by company insiders. Comparatively, 0.4% of Fortrea shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryGeneDx beats Fortrea on 12 of the 17 factors compared between the two stocks. Get Fortrea News Delivered to You Automatically Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTRE vs. The Competition Export to ExcelMetricFortreaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$845.35M$3.35B$6.09B$10.54BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-0.8921.5785.5527.60Price / Sales0.34271.43537.79201.45Price / Cash5.9247.1237.9261.55Price / Book0.6710.1412.996.76Net Income-$328.50M-$52.31M$3.30B$275.88M7 Day Performance5.52%5.14%4.33%2.81%1 Month Performance0.60%14.68%9.48%9.24%1 Year Performance-47.10%30.98%84.61%35.42% Fortrea Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTREFortrea3.0421 of 5 stars$10.13+8.8%$12.17+20.1%-45.7%$845.35M$2.70B-0.8915,500News CoverageAnalyst ForecastGap UpWGSGeneDx2.2886 of 5 stars$120.19+1.6%$104.13-13.4%+125.8%$3.40B$305.45M2,403.801,200Analyst ForecastHTFLHeartflowN/A$37.28-1.0%$36.60-1.8%N/A$3.14BN/A0.00699PRVAPrivia Health Group3.7545 of 5 stars$24.13+0.2%$28.58+18.5%+43.6%$2.96B$1.74B219.381,140Positive NewsAnalyst ForecastVCYTVeracyte3.6775 of 5 stars$36.04+0.1%$40.90+13.5%+4.8%$2.83B$445.76M109.22790Analyst UpgradeInsider TradeSGRYSurgery Partners3.1994 of 5 stars$20.39-3.6%$31.43+54.1%-30.4%$2.71B$3.24B-14.2615,000News CoveragePositive NewsAnalyst ForecastCONConcentra Group Holdings Parent2.8656 of 5 stars$20.65-0.5%$27.75+34.4%+5.5%$2.66B$1.90B17.3511,250Analyst ForecastGRALGRAIL1.1842 of 5 stars$61.70-5.9%$56.67-8.2%+459.9%$2.36B$125.60M-4.711,360Analyst ForecastInsider TradeLFSTLifeStance Health Group3.2061 of 5 stars$5.61+1.8%$8.50+51.5%-17.3%$2.14B$1.25B-112.2010,218Positive NewsAnalyst ForecastCELCCelcuity2.4688 of 5 stars$47.81-5.3%$56.50+18.2%+224.4%$2.14BN/A-13.8640Analyst ForecastADUSAddus HomeCare4.984 of 5 stars$112.70-1.9%$138.89+23.2%-11.4%$2.12B$1.27B24.8849,703Analyst Forecast Related Companies and Tools Related Companies WGS Competitors HTFL Competitors PRVA Competitors VCYT Competitors SGRY Competitors CON Competitors GRAL Competitors LFST Competitors CELC Competitors ADUS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTRE) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
